RGTI
Rigetti Computing
-- 17.0800 TSLA
Tesla
-- 431.660 NVDA
NVIDIA
-- 137.010 LAES
SEALSQ Corp
-- 9.080 PLTR
Palantir
-- 79.080 
Despite Changmao Biochemical Engineering's higher revenue gr...
Despite Changmao Biochemical Engineering's higher revenue growth, its P/S ratio aligns with the industry, possibly due to potential risks. Investors anticipate future revenue volatility.
Market Cool On Changmao Biochemical Engineering Company Limited's (HKG:954) Revenues Pushing Shares 28% Lower
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment